Jinbo Zhao

Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE)

Xiaolong Yan, Hongtao Duan, Yunfeng Ni et al. · International Journal of Surgery · 2022 · 234 citations

Medicine, Oncology, Surgery +13

Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice

Yunfeng Ni, Jian Wang, Xiaolong Yan et al. · Respiratory Research · 2010 · 130 citations · Full text

Medicine, Immunology, Pharmacology +16

Inhibition of LDH-A by Oxamate Enhances the Efficacy of Anti-PD-1 Treatment in an NSCLC Humanized Mouse Model

Tianyun Qiao, Yanlu Xiong, Yangbo Feng et al. · Frontiers in Oncology · 2021 · 108 citations · Full text

Medicine, Oncology, Pharmacology +17

α1-Antitrypsin inhibits ischemia reperfusion-induced lung injury by reducing inflammatory response and cell death

Wenxi Gao, Jinbo Zhao, Hyunhee Kim et al. · The Journal of Heart and Lung Transplantation · 2013 · 107 citations

Veterinary Medicine, Immunology, Pharmacology +16

Neoadjuvant Camrelizumab Plus Platinum-Based Chemotherapy vs Chemotherapy Alone for Chinese Patients With Resectable Stage IIIA or IIIB (T3N2) Non–Small Cell Lung Cancer

Jie Lei, Jinbo Zhao, Li Gong et al. · JAMA Oncology · 2023 · 98 citations · Full text

Medicine, Oncology, Pharmacotherapy +17